Kuneman, Jurrien H. http://orcid.org/0000-0003-2162-2768
Butcher, Steele C. http://orcid.org/0000-0001-8258-8802
Stassen, Jan http://orcid.org/0000-0001-9745-5498
Singh, Gurpreet K.
Pio, Stephan M.
van der Kley, Frank
Ajmone Marsan, Nina http://orcid.org/0000-0001-7208-5769
Knuuti, Juhani http://orcid.org/0000-0003-3156-9593
Bax, Jeroen J.
Delgado, Victoria http://orcid.org/0000-0002-9841-2737
Funding for this research was provided by:
European Society of Cardiology (App000064741, T-2018-17405)
Article History
Received: 27 January 2022
Accepted: 10 March 2022
First Online: 21 April 2022
Declarations
:
: The department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands has received unrestricted research grants from Abbot Vascular, Bayer, Bioventrix, GE Healthcare, Ionis, Medtronic, Biotronik, Boston Scientific, and Edwards Lifesciences. Jeroen J. Bax and Nina Ajmone Marsan received speaker fees from Abbot Vascular. Victoria Delgado received speaker fees from Abbott Vascular, Edwards Lifesciences, GE Healthcare, MSD, Novartis and Medtronic. Juhani Knuuti received consultancy fees from GE Healthcare and AstraZeneca and speaker fees from GE Healthcare, Bayer, Lundbeck, Boehringer-Ingelheim, Pfizer and Merck, outside of the submitted work. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
: This retrospective analysis complies with the Declaration of Helsinki and was approved by the institutional review board of the Leiden University Medical Center Leiden, The Netherlands.
: The institutional review board of the Leiden University Medical Center Leiden, The Netherlands waived the need for written informed consent due to the retrospective study design.